A Familial Hypertrophic Cardiomyopathy α -Tropomyosin Mutation Causes Severe Cardiac Hypertrophy and Death in Mice
- 1 October 2001
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 33 (10), 1815-1828
- https://doi.org/10.1006/jmcc.2001.1445
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathiesJournal of Molecular Medicine, 2000
- Effect of Hypertrophic Cardiomyopathy Mutations in Human Cardiac Muscle α -tropomyosin (Asp175Asn and Glu180Gly) on the Regulatory Properties of Human Cardiac Troponin Determined by in vitro Motility AssayJournal of Molecular and Cellular Cardiology, 2000
- Properties of mutant contractile proteins that cause hypertrophic cardiomyopathyCardiovascular Research, 1999
- Mouse Model of a Familial Hypertrophic Cardiomyopathy Mutation in α-Tropomyosin Manifests Cardiac DysfunctionCirculation Research, 1999
- Familial Hypertrophic CardiomyopathyCirculation Research, 1998
- Effects of Two Familial Hypertrophic Cardiomyopathy-Causing Mutations on α-Tropomyosin Structure and FunctionBiochemistry, 1997
- The Management of Hypertrophic CardiomyopathyNew England Journal of Medicine, 1997
- Novel missense mutation in α-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathyJournal of Molecular and Cellular Cardiology, 1995
- α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomereCell, 1994
- Chromosomal Localization and Genomic Cloning of the Mouse α-Tropomyosin Gene Tpm-1Genomics, 1993